Abstract
Summary
An Automatic Blood Group Diagnostic Instrument is a medical device used to determine an individual’s blood type and Rh factor. Blood typing is crucial for blood transfusions, organ transplants, and prenatal care, as it helps prevent adverse reactions between incompatible blood types.
The global market for Automatic Blood Group Diagnostic Instrument was estimated to be worth US$ 1211 million in 2023 and is forecast to a readjusted size of US$ 2170.9 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030
The global automatic blood group diagnostic instrument market has been witnessing growth due to several factors. These include an increasing demand for blood transfusions, growing awareness about the importance of blood typing, and advancements in technology that have improved the accuracy and efficiency of these instruments.
The market is characterized by the presence of several key players offering a range of automatic blood group diagnostic instruments with different features and capabilities. These companies continuously strive to develop innovative products, expand their geographical reach, and engage in strategic partnerships to strengthen their market position.
Factors such as the rising prevalence of chronic diseases, expansion of healthcare infrastructure, and increasing investments in blood banks and diagnostics are also expected to drive market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automatic Blood Group Diagnostic Instrument, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Blood Group Diagnostic Instrument by region & country, by Type, and by Application.
The Automatic Blood Group Diagnostic Instrument market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Blood Group Diagnostic Instrument.
Market Segmentation
By Company
Hamilton Bonaduz AG
Diagnostic Grifols,S.A.
DIAGAST
Aikang
Beckman Coulter K.K.
G.S.G. RobotiX S.r.l.
Hybiome
Ortho-Clinical Diagnostics
Zhongshan Bio-tech
Shandong Xinhua Medical Instrument
WEGO
Segment by Type:
Nucleic Acid Amplification Techniques
Microbiological Technique
Immunohematology Techniques
Segment by Application
Blood Typing
Antibody Screening
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automatic Blood Group Diagnostic Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automatic Blood Group Diagnostic Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automatic Blood Group Diagnostic Instrument in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Automatic Blood Group Diagnostic Instrument was estimated to be worth US$ 1211 million in 2023 and is forecast to a readjusted size of US$ 2170.9 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030
The global automatic blood group diagnostic instrument market has been witnessing growth due to several factors. These include an increasing demand for blood transfusions, growing awareness about the importance of blood typing, and advancements in technology that have improved the accuracy and efficiency of these instruments.
The market is characterized by the presence of several key players offering a range of automatic blood group diagnostic instruments with different features and capabilities. These companies continuously strive to develop innovative products, expand their geographical reach, and engage in strategic partnerships to strengthen their market position.
Factors such as the rising prevalence of chronic diseases, expansion of healthcare infrastructure, and increasing investments in blood banks and diagnostics are also expected to drive market growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automatic Blood Group Diagnostic Instrument, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Blood Group Diagnostic Instrument by region & country, by Type, and by Application.
The Automatic Blood Group Diagnostic Instrument market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Blood Group Diagnostic Instrument.
Market Segmentation
By Company
Hamilton Bonaduz AG
Diagnostic Grifols,S.A.
DIAGAST
Aikang
Beckman Coulter K.K.
G.S.G. RobotiX S.r.l.
Hybiome
Ortho-Clinical Diagnostics
Zhongshan Bio-tech
Shandong Xinhua Medical Instrument
WEGO
Segment by Type:
Nucleic Acid Amplification Techniques
Microbiological Technique
Immunohematology Techniques
Segment by Application
Blood Typing
Antibody Screening
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automatic Blood Group Diagnostic Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automatic Blood Group Diagnostic Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automatic Blood Group Diagnostic Instrument in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Automatic Blood Group Diagnostic Instrument Product Introduction
1.2 Global Automatic Blood Group Diagnostic Instrument Market Size Forecast
1.2.1 Global Automatic Blood Group Diagnostic Instrument Sales Value (2019-2030)
1.2.2 Global Automatic Blood Group Diagnostic Instrument Sales Volume (2019-2030)
1.2.3 Global Automatic Blood Group Diagnostic Instrument Sales Price (2019-2030)
1.3 Automatic Blood Group Diagnostic Instrument Market Trends & Drivers
1.3.1 Automatic Blood Group Diagnostic Instrument Industry Trends
1.3.2 Automatic Blood Group Diagnostic Instrument Market Drivers & Opportunity
1.3.3 Automatic Blood Group Diagnostic Instrument Market Challenges
1.3.4 Automatic Blood Group Diagnostic Instrument Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automatic Blood Group Diagnostic Instrument Players Revenue Ranking (2023)
2.2 Global Automatic Blood Group Diagnostic Instrument Revenue by Company (2019-2024)
2.3 Global Automatic Blood Group Diagnostic Instrument Players Sales Volume Ranking (2023)
2.4 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Company Players (2019-2024)
2.5 Global Automatic Blood Group Diagnostic Instrument Average Price by Company (2019-2024)
2.6 Key Manufacturers Automatic Blood Group Diagnostic Instrument Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Automatic Blood Group Diagnostic Instrument Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Automatic Blood Group Diagnostic Instrument
2.9 Automatic Blood Group Diagnostic Instrument Market Competitive Analysis
2.9.1 Automatic Blood Group Diagnostic Instrument Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Automatic Blood Group Diagnostic Instrument Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Blood Group Diagnostic Instrument as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nucleic Acid Amplification Techniques
3.1.2 Microbiological Technique
3.1.3 Immunohematology Techniques
3.2 Global Automatic Blood Group Diagnostic Instrument Sales Value by Type
3.2.1 Global Automatic Blood Group Diagnostic Instrument Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Automatic Blood Group Diagnostic Instrument Sales Value, by Type (2019-2030)
3.2.3 Global Automatic Blood Group Diagnostic Instrument Sales Value, by Type (%) (2019-2030)
3.3 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Type
3.3.1 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Automatic Blood Group Diagnostic Instrument Sales Volume, by Type (2019-2030)
3.3.3 Global Automatic Blood Group Diagnostic Instrument Sales Volume, by Type (%) (2019-2030)
3.4 Global Automatic Blood Group Diagnostic Instrument Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Typing
4.1.2 Antibody Screening
4.1.3 Others
4.2 Global Automatic Blood Group Diagnostic Instrument Sales Value by Application
4.2.1 Global Automatic Blood Group Diagnostic Instrument Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Automatic Blood Group Diagnostic Instrument Sales Value, by Application (2019-2030)
4.2.3 Global Automatic Blood Group Diagnostic Instrument Sales Value, by Application (%) (2019-2030)
4.3 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Application
4.3.1 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Automatic Blood Group Diagnostic Instrument Sales Volume, by Application (2019-2030)
4.3.3 Global Automatic Blood Group Diagnostic Instrument Sales Volume, by Application (%) (2019-2030)
4.4 Global Automatic Blood Group Diagnostic Instrument Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Automatic Blood Group Diagnostic Instrument Sales Value by Region
5.1.1 Global Automatic Blood Group Diagnostic Instrument Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Automatic Blood Group Diagnostic Instrument Sales Value by Region (2019-2024)
5.1.3 Global Automatic Blood Group Diagnostic Instrument Sales Value by Region (2025-2030)
5.1.4 Global Automatic Blood Group Diagnostic Instrument Sales Value by Region (%), (2019-2030)
5.2 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Region
5.2.1 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Region (2019-2024)
5.2.3 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Region (2025-2030)
5.2.4 Global Automatic Blood Group Diagnostic Instrument Sales Volume by Region (%), (2019-2030)
5.3 Global Automatic Blood Group Diagnostic Instrument Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
5.4.2 North America Automatic Blood Group Diagnostic Instrument Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
5.5.2 Europe Automatic Blood Group Diagnostic Instrument Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
5.6.2 Asia Pacific Automatic Blood Group Diagnostic Instrument Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
5.7.2 South America Automatic Blood Group Diagnostic Instrument Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
5.8.2 Middle East & Africa Automatic Blood Group Diagnostic Instrument Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automatic Blood Group Diagnostic Instrument Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Automatic Blood Group Diagnostic Instrument Sales Value
6.2.1 Key Countries/Regions Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.2.2 Key Countries/Regions Automatic Blood Group Diagnostic Instrument Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.3.2 United States Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.4.2 Europe Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.5.2 China Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.5.3 China Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.6.2 Japan Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.7.2 South Korea Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.8.2 Southeast Asia Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Automatic Blood Group Diagnostic Instrument Sales Value, 2019-2030
6.9.2 India Automatic Blood Group Diagnostic Instrument Sales Value by Type (%), 2023 VS 2030
6.9.3 India Automatic Blood Group Diagnostic Instrument Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Hamilton Bonaduz AG
7.1.1 Hamilton Bonaduz AG Company Information
7.1.2 Hamilton Bonaduz AG Introduction and Business Overview
7.1.3 Hamilton Bonaduz AG Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Hamilton Bonaduz AG Automatic Blood Group Diagnostic Instrument Product Offerings
7.1.5 Hamilton Bonaduz AG Recent Development
7.2 Diagnostic Grifols,S.A.
7.2.1 Diagnostic Grifols,S.A. Company Information
7.2.2 Diagnostic Grifols,S.A. Introduction and Business Overview
7.2.3 Diagnostic Grifols,S.A. Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Diagnostic Grifols,S.A. Automatic Blood Group Diagnostic Instrument Product Offerings
7.2.5 Diagnostic Grifols,S.A. Recent Development
7.3 DIAGAST
7.3.1 DIAGAST Company Information
7.3.2 DIAGAST Introduction and Business Overview
7.3.3 DIAGAST Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DIAGAST Automatic Blood Group Diagnostic Instrument Product Offerings
7.3.5 DIAGAST Recent Development
7.4 Aikang
7.4.1 Aikang Company Information
7.4.2 Aikang Introduction and Business Overview
7.4.3 Aikang Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Aikang Automatic Blood Group Diagnostic Instrument Product Offerings
7.4.5 Aikang Recent Development
7.5 Beckman Coulter K.K.
7.5.1 Beckman Coulter K.K. Company Information
7.5.2 Beckman Coulter K.K. Introduction and Business Overview
7.5.3 Beckman Coulter K.K. Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Beckman Coulter K.K. Automatic Blood Group Diagnostic Instrument Product Offerings
7.5.5 Beckman Coulter K.K. Recent Development
7.6 G.S.G. RobotiX S.r.l.
7.6.1 G.S.G. RobotiX S.r.l. Company Information
7.6.2 G.S.G. RobotiX S.r.l. Introduction and Business Overview
7.6.3 G.S.G. RobotiX S.r.l. Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.6.4 G.S.G. RobotiX S.r.l. Automatic Blood Group Diagnostic Instrument Product Offerings
7.6.5 G.S.G. RobotiX S.r.l. Recent Development
7.7 Hybiome
7.7.1 Hybiome Company Information
7.7.2 Hybiome Introduction and Business Overview
7.7.3 Hybiome Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hybiome Automatic Blood Group Diagnostic Instrument Product Offerings
7.7.5 Hybiome Recent Development
7.8 Ortho-Clinical Diagnostics
7.8.1 Ortho-Clinical Diagnostics Company Information
7.8.2 Ortho-Clinical Diagnostics Introduction and Business Overview
7.8.3 Ortho-Clinical Diagnostics Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Ortho-Clinical Diagnostics Automatic Blood Group Diagnostic Instrument Product Offerings
7.8.5 Ortho-Clinical Diagnostics Recent Development
7.9 Zhongshan Bio-tech
7.9.1 Zhongshan Bio-tech Company Information
7.9.2 Zhongshan Bio-tech Introduction and Business Overview
7.9.3 Zhongshan Bio-tech Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zhongshan Bio-tech Automatic Blood Group Diagnostic Instrument Product Offerings
7.9.5 Zhongshan Bio-tech Recent Development
7.10 Shandong Xinhua Medical Instrument
7.10.1 Shandong Xinhua Medical Instrument Company Information
7.10.2 Shandong Xinhua Medical Instrument Introduction and Business Overview
7.10.3 Shandong Xinhua Medical Instrument Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shandong Xinhua Medical Instrument Automatic Blood Group Diagnostic Instrument Product Offerings
7.10.5 Shandong Xinhua Medical Instrument Recent Development
7.11 WEGO
7.11.1 WEGO Company Information
7.11.2 WEGO Introduction and Business Overview
7.11.3 WEGO Automatic Blood Group Diagnostic Instrument Sales, Revenue and Gross Margin (2019-2024)
7.11.4 WEGO Automatic Blood Group Diagnostic Instrument Product Offerings
7.11.5 WEGO Recent Development
8 Industry Chain Analysis
8.1 Automatic Blood Group Diagnostic Instrument Industrial Chain
8.2 Automatic Blood Group Diagnostic Instrument Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Automatic Blood Group Diagnostic Instrument Sales Model
8.5.2 Sales Channel
8.5.3 Automatic Blood Group Diagnostic Instrument Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer